The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condition in African American (AA) female family caregivers, at high risk for Alzheimer's disease (AD).
Age range
45 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in interleukin-7
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in interleukin-8
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in interleukin-9
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in Interleukin-10
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in interferon induced protein 10
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in macrophage derived chemokine
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in monocyte chemoattractant protein 1
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in transforming growth factor alpha
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in tumor necrosis factor alpha
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in C-reactive protein
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks
Change in serum amyloid protein
Timeframe: Before and after the intervention / control at least 20 times during 12 weeks